Recently, it was shown that pharmacological interventions to stimulate the uptake of glutamate by astrocytic glutamate transporters (EAAT2/GLT1) prevented excitotoxic neuronal death in a transgenic mouse model of FTD pathology [52]. The gene discussed is SLC1A2; the disease is frontotemporal dementia.